Home / Stocks / Indraprastha Medical Corp
INDRAMEDCO

Indraprastha Medical Corp Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 28 Sep 2026

₹360.0

Change

-5.7 (-1.56%)

Open

₹366.8

Prev. Close

₹365.7

Day High

₹366.8

Day Low

₹358.6

Volume Analysis

Traded

211,930

Delivered

147,370

Delivery %

69.54%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹373.2 ₹370.0 ₹365.0 ₹361.8 ₹356.8 ₹353.6 ₹348.6
Fibonacci ₹370.0 ₹366.87 ₹364.93 ₹361.8 ₹358.67 ₹356.73 ₹353.6
Camarilla ₹362.26 ₹361.5 ₹360.75 ₹361.8 ₹359.25 ₹358.5 ₹357.75

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-20.1%

1 Week

-0.26%

1 Month

-2.19%

3 Months

-6.88%

6 Months

-9.91%

1 Year

-18.56%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.

TopFund Analysis

Indraprastha Medical Corp lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 61/100. The strongest factor is Corporate Governance (85/100), while Institutional Ownership (32/100) is the weakest area to weigh before deciding. FII holding has been rising.

TopFund Score — Fundamentals Quality

61/100 — Average

Data confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 28 Sep 2026 · How we calculate this →

Corporate Governance

85

Institutional Ownership

32

Risk & Volatility

48

Liquidity

84

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

We hereby submit the copies of public notice for transfer of shares to IEPF, published on 15th September,2026 in the Financial Express, all India edition …

We hereby submit copies of the public notice of the 38th AGM, published in the finacial express all India editions in english language and in …

FY26 annual report filed; AGM on 24 Sept 2026, dividend ₹4 per share declared.

Source: BSE regulatory filings, via Screener.in.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 51.0% → 51.0%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 41.49% 41.69% 43.01% 44.14% 43.16% 42.91% 42.5% 42.74% 43.08% 45.43% 45.69% 45.65%
Promoters 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0% 51.0%
FII 0.81% 0.95% 1.08% 1.7% 2.64% 2.88% 2.94% 2.73% 2.41% 2.72% 2.43% 2.77%
DII 6.71% 6.36% 4.91% 3.14% 3.19% 3.18% 3.56% 3.56% 3.51% 0.82% 0.87% 0.59%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Indraprastha Medical Corp (this stock) — — — —
Sun Pharmaceutical Ind L 444,405 35.2 5.32 16.0%
Divi S Laboratories Ltd 255,487 85.8 15.25 16.5%
Torrent Pharmaceuticals L 189,746 85.0 20.11 27.4%
Apollo Hospitals Enter. L 128,055 60.9 13.51 21.2%
Zydus Lifesciences Ltd 120,089 24.7 4.48 21.2%
Cipla Ltd 111,985 31.3 3.25 11.6%

Which Mutual Funds Hold Indraprastha Medical Corp?

Frequently Asked Questions about Indraprastha Medical Corp

Community Sentiment

What are other investors saying about Indraprastha Medical Corp?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.